Company intelligence / Profile preview

PERSONeM

United States

Ownership: Private
Development stage: Other

Overview

Persona Biomed, Inc. (PERSONeM) is a clinical-stage biotechnology company dedicated to advancing precision medicine through the integration of molecular diagnostics and targeted drug discovery. Founded in 2015, the company develops proprietary laboratory technologies and analytical tools that utilize clinical biomarkers to improve patient outcomes. PERSONeM's portfolio includes patented diagnostic systems and a pipeline of therapeutic programs focused on personalized treatment strategies. The company is currently transitioning from a research-intensive focus to the commercialization of its medical technology products and services globally.

Therapeutic areas: Oncology
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on PERSONeM.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PERSONeM.

Explore the full profile